# Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma

> **NCT02108145** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Air Force Military Medical University, China** · enrollment: 70 (estimated)

## Conditions studied

- Hilar Cholangiocarcinoma

## Interventions

- **PROCEDURE:** bilateral metal stent insertion
- **PROCEDURE:** unilateral metal stent insertion

## Key facts

- **NCT ID:** NCT02108145
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02108145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02108145, "Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02108145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*